Investors are frustrated with Botox-maker Allergan — and its CEO says it’s ‘deep into the process’ of figuring out what to do next (AGN)

Reuters

• Allergan said Monday during its first-quarter earnings call that it’s “deep into the process” of its strategic review of the company amid its stock price slipping over the past year. 
• Allergan CEO Brent Saunders outlined five possible approaches the company’s exploring, which include divesting certain businesses. 
• Investors, Saunders said, are frustrated, and some of Allergan’s top shareholders have approached activist investors to get involved in pushing for change at the company, Business Insider reported on Thursday. 

Allergan knows its investors are frustrated. 

Botox-maker Allergan reported its first-quarter earnings on Monday, announcing a better-than-expected profit and raising its forecast for the year. Still, the company’s stock fell by 3% Monday morning. 

See the rest of the story at Business Insider

NOW WATCH: A $ 163 billion chief economist outlines his biggest market fear

See Also:

• GM beats on earnings for 1st quarter
• Ford beats on first-quarter earnings — but kills sedans in USA
• Harley-Davidson beats on earnings and shares are rising in pre-market trading

SEE ALSO: Pharma dealmaking is starting to heat up — here’s who likely to get acquired

DON’T MISS: Investors are angry with Botox-maker Allergan — and they’re trying to get an activist involved to shake it up